Novo CEO sees obesity pill opening doors to new markets
- Posted on January 12, 2026
- By Financial Post
- 4 Views
Novo CEO sees obesity pill opening doors to new markets
Novo Nordisk A/S’s obesity pill will allow it to tap into a massive population of patients not yet taking GLP-1s. Find out more here
